Biochemistry I - Week 6 - Extracellular Matrix
Extracellular Matrix (ECM)
Network filling spaces between cells.
Provides structure, shapes tissues, and links cells and tissues.
Example: In skin, ECM supports fibroblasts and blood vessels.
Key in tissues like tendons and cartilage.
Forms basement membranes (basal lamina) which support epithelial cells, muscle and adipose cells.
Key components:
Fibrous Structural Proteins: Collagen, elastin, and laminin (basement membrane component). Provide strength and flexibility.
Proteoglycans: Core protein with glycosaminoglycans (GAG). GAGs have repeating disaccharide units (hexosamine and uronic acid, often sulfated). Essential for ECM hydration and support. Synthesis starts with sugar attachment to serine, threonine, or asparagine residues (in ER and Golgi).
Adhesion Proteins: Fibronectin and laminin. Link ECM components and anchor cells via integrins, connecting ECM to cytoskeleton and allowing cell signaling. Integrins, Type IV collagen, Actin.
Fibrous Proteins
Folded into filaments or sheets with repeated amino acid sequences.
Not water-soluble.
Provide strength and support.
Examples: collagen and elastin.
Collagen: strength and support.
Elastin: allows stretch and return to original shape.
Found in skin, connective tissues, blood vessel walls, sclera, and cornea.
Collagen: Most common protein in the human body.
Structure: Three polypeptide α chains in a triple helix (rope-like).
Organization varies based on role:
Gel-like: Support in ECM or eye's vitreous humor.
Tight, parallel fibers: Strength in tendons.
Arranged for light passage: Cornea.
Angled fibers: Resist forces in bones.
Every third amino acid in the chain is glycine (Gly-X-Y). Smallest side chain allows tight helix formation.
Collagen (Types)
Collagen superfamily: >25 types, based on α chain amino acid sequence variations.
Three groups:
Fibril-forming collagens: Types I, II, and III (rope-like).
Network-forming collagens: Types IV and VIII (3D network).
Fibril-associated collagens: Types IX and XII (link fibrils to each other and ECM).
Type I:
Most common (90%).
Found in bone (made by osteoblasts), skin, tendons, dentin, fascia, cornea, and during late wound repair.
Deficiency: Osteogenesis imperfecta type I.
Type II:
Found in Cartilage (including hyaline), vitreous body, nucleus pulposus.
Type III (Reticulin):
Found in skin, blood vessels, uterus, fetal tissue. Important in wound healing.
Deficiency: Vascular type of Ehlers-Danlos syndrome (Type IV Ehlers-Danlos syndrome).
Type IV:
Found in Basement membrane (glomerulus, cochlea), lens.
Defective in Alport syndrome; targeted by autoantibodies in Goodpasture syndrome.
Collagen Biosynthesis
Mutated type I collagen gene: Disrupts prepro-α chain formation (step 1) → Osteogenesis imperfecta.
Mutated type IV collagen gene: Disrupts prepro-α chain formation (step 1) → Alport syndrome.
After signal sequence cleavage, collagen pro-α chain is formed (step 2).
Proline hydroxylase and lysine hydroxylase act on the chain, requiring vitamin C as cofactor (step 3).
Genetic defect in these enzymes: type VI Ehlers-Danlos syndrome (kyphoscoliotic type).
Vitamin C deficiency: Scurvy. Both disrupt hydroxylation.
Hydroxylysine residues receive sugar chains (glycosylation, step 4).
Procollagen forms via triple helix assembly of three α chains, stabilized by hydrogen and disulfide bonds (step 5).
Disruption of the triple helix formation can lead to type 1 Osteogenesis imperfecta.
Procollagen is secreted (step 6).
N- and C-terminal peptides are cleaved by proteases (e.g., procollagen peptidase) forming tropocollagen (step 7).
Tropocollagen self-assembles into collagen fibrils (still elastic).
Lysyl oxidase (copper cofactor) oxidizes hydroxylysine residues (step 8).
Oxidation enables collagen crosslinking, making collagen rigid.
Problems in crosslinking: Menkes disease.
Lysine residues must be hydroxylated for lysyl oxidase to function.
Scurvy or type VI Ehlers-Danlos: Lack of hydroxylation prevents oxidation, leaving collagen elastic → elastic skin and fragile blood vessels.
Collagen fibrils aggregate to form collagen fibers (step 9).
Collagenopathies
Osteogenesis imperfecta (brittle bone disease):
Genetic, defects in COL1A1 and COL1A2 genes.
Most common form: Autosomal dominant, decreased type I collagen production, altered triple helix formation.
Clinical manifestations:
Multiple fractures and bone deformities after minimal trauma.
Blue sclerae (translucent connective tissue).
Tooth abnormalities (opalescent teeth, lack of dentin).
Conductive hearing loss (abnormal ossicles).
Treatment: bisphosphonates.
Ehlers-Danlos syndrome:
Faulty collagen synthesis.
Hyperextensible skin, hypermobile joints, easy bruising.
Multiple types, varying inheritance and severity. Autosomal dominant or recessive.
Associated with joint dislocations, berry and aortic aneurysms, and organ ruptures.
The hypermobility type (joint instability) is the most common type.
The classical type, which presents with hypermobile joints and skin symptoms (stretchy skin), is caused by mutations in type V collagen (e.g. COL5A1 and COL5A2).
The vascular type (type IV Ehlers-Danlos syndrome) is characterized by fragile tissues, including blood vessels (e.g., aorta), muscles, and organs that are prone to rupture (e.g. gravid uterus). Patients are prone to have berry aneurysms, aortic aneurysms, and mitral valve prolapse. This condition is caused by mutations in type III procollagen (e.g. COL3A1).
Can result from procollagen peptidase deficiency.
Menkes Disease:
X-linked recessive connective tissue disorder. Impaired copper absorption and transport (defective Menkes protein - ATP7A).
Absent copper → decreased lysyl oxidase activity (copper cofactor for collagen cross-linking).
Results in brittle, "kinky" hair, growth and developmental delays, hypotonia, increased risk of cerebral aneurysms.
Alport syndrome:
Genetic disorder: progressive kidney disease, hearing loss, and eye abnormalities.
Mutations in type IV collagen genes (glomerular basement membrane).
Inheritance: X-linked, autosomal recessive, or autosomal dominant (X-linked most common/severe).
Kidney damage → end-stage renal disease (2nd-3rd decade).
Hematuria, proteinuria, hypertension.
Scurvy:
Vitamin C (ascorbic acid) deficiency.
Swollen and bleeding gums, easy bruising, petechiae, hemarthrosis, anemia, poor wound healing, perifollicular hemorrhages, subperiosteal hemorrhages, “corkscrew” hair, weakened immune response.
Elastin
Fibrous protein with rubber-like properties (elasticity).
Precursor: tropoelastin (rich in non-hydroxylated proline, glycine, and lysine residues).
Elastic fibers: elastin and glycoprotein microfibrils. Found in lungs, large arteries, and elastic ligaments.
Can stretch several times their original length and recoil.
Tropoelastin secreted into ECM interacts with microfibrils.
Microfibrils: multiple glycoproteins like fibrillin.
Lysyl oxidase modifies lysine side chains in tropoelastin to allysine residues.
Three allysine residues and one unchanged lysine form a desmosine cross-link (stretchy, elastic network).
Tropoelastin → Attaches to Microfibrils → Modified by Lysyl Oxidase → Cross-Linking Occurs → Formation of Elastin Fibers.
Marfan Syndrome
Autosomal dominant connective tissue disorder (variable expression).
Mutation in FBN1 gene (chromosome 15) → defective fibrillin-1 (glycoprotein sheath around elastin).
Clinical manifestations:
Tall stature with long extremities.
Chest wall deformities (pectus carinatum or pectus excavatum).
Hypermobile joints.
Long, tapering fingers and toes (arachnodactyly).
Cystic medial necrosis of the aorta (defective fibrillin-1 → degeneration of elastic fibers in the aorta).
Aortic root aneurysm (rupture or dissection; most common cause of death).
Mitral valve prolapse (abnormal connective tissue in heart valves).
Increased risk of spontaneous pneumothorax.
Upward and temporal dislocation of the lens (defective fibrillin-1 weakens suspensory ligaments).
α1-Antitrypsin
Elastin is degraded by elastases.
α1-antitrypsin (AAT) inhibits proteolytic enzymes (peptidases, proteases, or proteinases) that hydrolyze and destroy proteins.
AAT inhibits neutrophil elastase (degrades elastin of alveolar walls).
AAT synthesized by the liver and also extrahepatically.
AAT deficiency:
Genetic disorder: reduced levels or dysfunctional AAT.
Autosomal codominant: most severe cases associated with Z allele (PiZZ genotype) of the SERPINA1 gene.
Misfolded AAT accumulates in the endoplasmic reticulum of liver cells.
Without AAT:
Unregulated elastase activity → excessive elastin breakdown in connective tissues, especially lungs.
Early-onset panacinar emphysema (uniform destruction) characterized by uniform destruction of the entire acinar structure, including both respiratory bronchioles and alveolar sacs.
Respiratory symptoms: shortness of breath, wheezing, mucus production, and chronic cough.
Liver damage:
Accumulation of misfolded AAT in hepatocytes → cirrhosis.
Increased risk of hepatocellular carcinoma (HCC).
Other liver complications can include impaired synthesis of coagulation factors, toxin accumulation (resulting in hepatic encephalopathy), portal hypertension (leading to esophageal varices), among other issues.
Laminin
Second most abundant protein in basal lamina after type IV collagen.
Supports tissues by binding to type IV collagen, other ECM molecules, and cell surface proteins.
Cross-shaped structure: α, β, and γ subunits.
Five α types (α1 to α5), three β types (β1 to β3), and three γ types (γ1 to γ3) → up to 45 combinations (18 identified).
Laminin 111: α1β1γ1.
Main structure: coiled α-helix linking subunits into a rod-like shape.
Extensions at N-terminal end of each chain, and C-terminal end of α- chain, connect with other ECM components.
Proteoglycans (Mucopolysaccharides)
Fibrous proteins in ECM are surrounded by proteoglycan gels.
Proteoglycans: core proteins linked to glycosaminoglycans (GAGs).
GAGs: repeating pairs of sugar units (N-acetyl glucosamine or N-acetyl galactosamine, and an acidic sugar).
Sugars are often sulfated.
Single proteoglycan: >100 GAG chains.
Carboxylate and sulfate groups: negative charge, attract positive ions and form hydrogen bonds with water → hydrated gel.
Functions of the gel:
Flexible support to the ECM (provides resilience and flexibility to tissues like cartilage, allowing them to compress and then return to their original shape).
Filter for small molecules like ions (e.g. ) and water.
Slows movement of cells and larger molecules (act like "molecular sieves." This helps control which substances can enter or leave cells).
Lubricant.
Glycosaminoglycan (GAG): chain of repeated disaccharide units.
GAG name based on disaccharide composition.
Heparin: iduronic acid and N-sulfated glucosamine. Highly sulfated GAG. Anticoagulant that regulates blood coagulation.
Proteoglycans (Mucopolysaccharides) cont.
Protein component of proteoglycans is synthesized in the endoplasmic reticulum (ER), where initial glycosylation occurs.
UDP-sugars add sugar units one at a time to the protein and the growing carbohydrate chain.
Glycosylation continues in the Golgi complex, where specific enzymes called glycosyltransferases attach sugars based on the existing structure.
After the sugar chains are formed, sulfation occurs using 3′-phosphoadenosine 5′-phosphosulfate (PAPS) for sulfate groups.
An epimerase converts glucuronic acid to iduronic acid.
Proteoglycan resembles a bottlebrush.
Proteoglycans form large aggregates attached to hyaluronic acid via link proteins.
They interact with fibronectin, which connects to integrin proteins on the cell membrane, and also associate with collagen fibers to form the ECM.
Hyaluronan (Hyaluronate):
Unique GAG: Single, long chain.
Only GAG that is not sulfated (not covalently linked to a core protein).
Many proteoglycans interact with hyaluronic acid through their core proteins, forming aggregates.
Glycosaminoglycans
At least seven types of GAGs, each differing in their sugar components: chondroitin sulfate, dermatan sulfate, heparin, heparan sulfate, hyaluronic acid and keratan sulfates I and II.
Except for hyaluronic acid, GAGs are typically attached to proteins via covalent bonds to serine or threonine residues, while keratan sulfate I is linked to asparagine.
Each glycosaminoglycan has its own specific functions.
Heparin serves as an anticoagulant, preventing blood clotting and regulating various physiological processes.
Mucopolysaccharidoses
Lysosomal enzymes degrade proteoglycans.
Lysosomes contain endoglycosidases and exoglycosidases to break down glycosaminoglycans (GAGs).
Deficiency of lysosomal glycosidases (e.g. α-L-iduronidase and iduronate-2-sulfatase) causes accumulation of partially degraded proteoglycans within membrane-enclosed vesicles inside cells (residual bodies).
This accumulation can lead to marked enlargement of the organ and impairment of its function.
Mucopolysaccharidoses: clinical disorder caused by this.
Hurler syndrome (Gargoylism; Mucopolysaccharidosis type I):
Autosomal recessive disease.
α-L-iduronidase deficiency.
Accumulation of Heparan sulfate and Dermatan sulfate occurs.
Clinical manifestations: developmental delay, hirsutism, skeletal anomalies, airway obstruction (tracheal cartilage abnormalities), clouded cornea (abnormal arrangement of collagen fibers), hepatosplenomegaly, intellectual disability, recurrent infections (due to thick mucus), heart disease, and dysostosis multiplex on X-ray (skeletal abnormalities that occur due to abnormal development of bones and cartilage).
Hunter syndrome (Mucopolysaccharidosis type II):
X-linked recessive disease.
Iduronate-2-sulfatase deficiency.
Accumulation of Heparan sulfate and Dermatan sulfate occurs
Clinical manifestations: Mild Hurler (without corneal clouding) + aggressive behavior
Integrins
Important receptors on cell surface, connecting the cell's internal structure (cytoskeleton, mainly actin) to external proteins (fibronectin, collagen, and laminin).
Link the cell’s cytoskeleton to the ECM, thereby providing a stable environment for the cells.
Involved in a variety of cell signaling options.
Two subunits: alpha (α) and beta (β).
18 different alpha subunits and 8 different beta subunits, which combine to form 24 unique pairs.
Activation mechanisms:
Inside-Out Mechanism: Signals from inside the cell activate the integrins.
Outside-In Mechanism: Binding of external molecules activates the integrins and sends signals inside the cell.
Activated integrins help cells move through the ECM (important for growth, cellular differentiation, and cancer metastasis).
Heterodimers of α and β subunits.
Integrins Cont.
Integrins on white blood cells are usually inactive.
Infection: nearby cells release inflammatory mediators (C5a and LTB4) that activate integrins on white blood cells.
Activation allows white blood cells (neutrophils) to stick to blood vessel walls at the infection site (leukocyte adhesion).
Autosomal recessive β2-integrin (CD18) deficiency leads to defective neutrophil adhesion to blood vessel endothelial cells, preventing their migration to sites of inflammation.
Symptoms:
Delayed separation of the umbilical cord: After delivery, blood flow to the umbilical cord ceases, causing tissue necrosis. Neutrophils typically remove this necrotic tissue, so in β2-integrin deficiency, the lack of neutrophil migration delays cord separation.
Increased levels of circulating neutrophils: Due to defective integrin function, the number of neutrophils adhering to blood vessel walls (marginal neutrophils) is reduced, leading to higher levels of circulating (central) neutrophils.
Recurrent bacterial infections: Since neutrophils cannot migrate to infection sites, the body struggles to clear bacterial infections resulting in recurrent episodes. Additionally, because neutrophils are absent at the infection site, there is a lack of pus formation (which consists mainly of dead neutrophils).
Fibronectin
Adhesion protein connecting integrins to other ECM components.
Large, flexible protein with different binding sites (integrins, collagen, and glycosaminoglycans).
Links cell’s internal structure (actin cytoskeleton) and ECM.
Improperly functioning adhesion proteins: abnormal cell movement.
Fibronectin was initially identified as a "large, external transformation-sensitive protein" (LETS).
Many tumor cells produce lower levels of adhesion proteins, allowing them to move more freely in the ECM.
This increased movement can make it easier for tumor cells to spread to other areas in the body, a process known as metastasis.
Matrix Metalloproteinases
Extracellular matrix (ECM) contains enzymes called matrix metalloproteinases (MMPs).
Zinc-dependent enzymes that use zinc to help break down proteins in the ECM, including collagen and laminin.
Role: cell movement and tissue remodeling during growth and development.
Also release growth factors bound to ECM components.
Proper regulation of MMPs is essential for cell movement and growth.
Cancer cells use MMPs to remodel ECM for metastasis.
Regulation of MMP activity involves:
Transcriptional regulation
Activation
Inhibition by proteins like α2-macroglobulin and tissue inhibitors of metalloproteinases (TIMPs).
Coordinated regulation of TIMPs and MMPs is vital because an imbalance can lead to health issues like certain cancers and atherosclerosis.
Chondrocytes:
The cells found in articular cartilage that help in both making and breaking down this tissue.
The breakdown occurs when enzymes (MMPs) produced by these chondrocytes cleave proteoglycan aggregates.
During systemic lupus erythematosus (SLE):
Inflammation caused by the immune system attacking the body can harm the kidneys, skin, and other areas.
Joint pain is common due to the inflammation around the joints.
The inflammatory process leads to the release of cytokines like interleukin-1 (IL-1), which can increase the production of MMPs by chondrocytes.
As a result, important proteins like proteoglycans and other ECM proteins are lost, leading to joint damage and pain.